AdaptHealth Corp. (AHCO) Stock Forecast
AHCO analyst forecast
as of October 18, 2026- Analyst consensus
- Strong buy 4.86 / 5 from 7 analysts
- Price target
- $8.86 average of analyst targets
- Upside to target
- +47.1% from the latest close
- Next earnings
- November 3, 2026 EPS estimate $-0.06
- 52-week range
- $5.22 – $13.38
AHCO analyst ratings
7 analystsNumber of analysts at each rating.
AHCO price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
AHCO earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | −$0.06 | −$0.09 | −$0.05 | $0.23 | −127.4% | 5 |
| Current fiscal year (2026) | −$0.45 | −$1.46 | −$0.10 | $0.54 | −183.6% | 5 |
| Next fiscal year (2027) | −$0.13 | −$0.24 | $0.09 | −$0.45 | +72.2% | 5 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
AHCO revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $725.9M | $722.4M | $730.2M | −11.5% | 7 |
| Current fiscal year (2026) | $2.88B | $2.86B | $2.89B | −11.3% | 7 |
| Next fiscal year (2027) | $2.99B | $2.84B | $3.21B | +3.8% | 7 |
AHCO EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
AHCO revenue: reported and forecast
AHCO EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0.32 | −$0.06 | −$0.06 | −$0.06 | −$0.06 | −120.1% | 0 up · 0 down |
| Current fiscal year (2026) | $0.84 | −$0.45 | −$0.45 | −$0.45 | −$0.45 | −154.0% | 0 up · 0 down |
| Next fiscal year (2027) | $1.17 | −$0.13 | −$0.13 | −$0.12 | −$0.13 | −110.7% | 1 up · 1 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
AHCO earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; AHCO beat in 6 of 12.
What analysts expect from AHCO
7 analysts cover AdaptHealth; their consensus rating is strong buy (4.86 on a 1–5 scale, where 5 is a strong buy). The average price target is $8.86, 47.1% above the latest close of $6.02. Analysts expect earnings of −$0.45 per share for 2026, −183.6% from a year earlier. For 2027 the average estimate is −$0.13 per share on revenue of $3.0 billion. AdaptHealth beat the EPS estimate in 6 of the last 12 quarters.
Related: AHCO income statement, AHCO key metrics, AHCO chart. See the AHCO stock overview for the latest quote and news.
AHCO forecast FAQ
What is AdaptHealth's price target?
The average analyst price target for AdaptHealth is $8.86, 47.1% above the latest close of $6.02.
Is AdaptHealth a buy, hold or sell?
Of 7 analysts covering AdaptHealth, 6 rate it a strong buy, 1 a buy, 0 a hold, 0 a sell and 0 a strong sell, a consensus of strong buy. Ratings are opinions, not a recommendation from Quotelinks.
What is AdaptHealth's EPS forecast?
Analysts forecast −$0.45 per share for 2026 (range −$1.46 to −$0.10); for 2027 the estimate is −$0.13.
What is AdaptHealth's revenue forecast?
The average revenue estimate for 2026 is $2.9 billion, growth of −11.3%; for 2027 it is $3.0 billion.
When does AdaptHealth report earnings?
AdaptHealth is expected to report results for the quarter ending September 30, 2026 on November 3, 2026 before the market opens; the EPS estimate is $-0.06.
Does AdaptHealth usually beat earnings estimates?
AdaptHealth reported EPS at or above the analyst estimate in 6 of the last 12 quarters.